WASHINGTON -- U.S. researchers have begun a groundbreaking trial to test the potential of umbilical cord blood transplants, a kind of stem cell therapy, to treat and possibly reverse hearing loss in infants.

 A study from the University of Illinois has found that treating a Type 1 diabetic’s T-Cells with human cord blood stem cells may be a possible cure – helping restart the pancreatic function and insulin production.

Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood 

Eight-year-old Thamirabharuni and her one-year-old brother Pugazhendhi share a special kind of bond not commonly seen among siblings. Thanks to her brother, Thamirabharuni no longer suffers from thalassemia disease. 

Durham – A Duke University physician believes the key to curing, or at least lessening the severity of, cerebral palsy lies within cord blood stem cells, and she has begun a clinical trial to find out if that is true.